116 related articles for article (PubMed ID: 7825180)
21. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.
Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884
[TBL] [Abstract][Full Text] [Related]
22. Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides.
Elzagallaai AA; Sultan EA; Bend JR; Abuzgaia AM; Loubani E; Rieder MJ
J Clin Pharmacol; 2020 Mar; 60(3):409-421. PubMed ID: 31709574
[TBL] [Abstract][Full Text] [Related]
23. In vitro formation, disposition and toxicity of N-acetoxy-sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity.
Nakamura H; Uetrecht J; Cribb AE; Miller MA; Zahid N; Hill J; Josephy PD; Grant DM; Spielberg SP
J Pharmacol Exp Ther; 1995 Sep; 274(3):1099-104. PubMed ID: 7562475
[TBL] [Abstract][Full Text] [Related]
24. Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein tat.
Arp J; Rieder MJ; Urquhart B; Freeman D; Tucker MJ; Krizova A; Lehmann D; Dekaban GA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1218-25. PubMed ID: 15933158
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxicity of oxidative metabolites of procainamide.
Rubin RL; Uetrecht JP; Jones JE
J Pharmacol Exp Ther; 1987 Sep; 242(3):833-41. PubMed ID: 3656116
[TBL] [Abstract][Full Text] [Related]
26. Severe multisystem disease caused by trimethoprim-sulfamethoxazole: possible role of an in vitro lymphocyte assay.
Epstein M; Wright JM
J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):416-7. PubMed ID: 2212414
[No Abstract] [Full Text] [Related]
27. Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling.
Sanderson JP; Naisbitt DJ; Farrell J; Ashby CA; Tucker MJ; Rieder MJ; Pirmohamed M; Clarke SE; Park BK
J Immunol; 2007 May; 178(9):5533-42. PubMed ID: 17442935
[TBL] [Abstract][Full Text] [Related]
28. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells.
Hopkins JE; Naisbitt DJ; Humphreys N; Dearman RJ; Kimber I; Park BK
Toxicology; 2005 Jan; 206(2):221-31. PubMed ID: 15588915
[TBL] [Abstract][Full Text] [Related]
29. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.
Reilly TP; Lash LH; Doll MA; Hein DW; Woster PM; Svensson CK
J Invest Dermatol; 2000 Jun; 114(6):1164-73. PubMed ID: 10844561
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone.
Reilly TP; Bellevue FH; Woster PM; Svensson CK
Biochem Pharmacol; 1998 Mar; 55(6):803-10. PubMed ID: 9586952
[TBL] [Abstract][Full Text] [Related]
31. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides.
Gupta A; Eggo MC; Uetrecht JP; Cribb AE; Daneman D; Rieder MJ; Shear NH; Cannon M; Spielberg SP
Clin Pharmacol Ther; 1992 Jan; 51(1):56-67. PubMed ID: 1732077
[TBL] [Abstract][Full Text] [Related]
32. Suppression of T-lymphocyte proliferation by sulphonamide hydroxylamines.
Rieder MJ; Sisson E; Bird IA; Almawi WY
Int J Immunopharmacol; 1992 Oct; 14(7):1175-80. PubMed ID: 1452402
[TBL] [Abstract][Full Text] [Related]
33. The hydroxylamine of sulfamethoxazole and adverse reactions in patients with acquired immunodeficiency syndrome.
Lee BL; Delahunty T; Safrin S
Clin Pharmacol Ther; 1994 Aug; 56(2):184-9. PubMed ID: 8062495
[TBL] [Abstract][Full Text] [Related]
34. Cellular toxicity of sulfamethoxazole reactive metabolites--II. Inhibition of natural killer activity in human peripheral blood mononuclear cells.
Leeder JS; Nakhooda A; Spielberg SP; Dosch HM
Biochem Pharmacol; 1991 Feb; 41(4):575-83. PubMed ID: 1997006
[TBL] [Abstract][Full Text] [Related]
35. The effect of cimetidine on the formation of sulfamethoxazole hydroxylamine in patients with human immunodeficiency virus.
Lehmann DF; Newman N; Morse PD
J Clin Pharmacol; 1998 May; 38(5):463-6. PubMed ID: 9602961
[TBL] [Abstract][Full Text] [Related]
36. Production of tumour necrosis factor by cells exposed to sulphonamide reactive metabolites.
Rieder MJ; Mask M; Bird IA
Can J Physiol Pharmacol; 1992 May; 70(5):719-22. PubMed ID: 1423015
[TBL] [Abstract][Full Text] [Related]
37. The predictive value of the in vitro platelet toxicity assay (iPTA) for the diagnosis of hypersensitivity reactions to sulfonamides.
Elzagallaai AA; Koren G; Rieder MJ
J Clin Pharmacol; 2013 Jun; 53(6):626-32. PubMed ID: 23670648
[TBL] [Abstract][Full Text] [Related]
38. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.
Naisbitt DJ; Gordon SF; Pirmohamed M; Burkhart C; Cribb AE; Pichler WJ; Park BK
Br J Pharmacol; 2001 May; 133(2):295-305. PubMed ID: 11350866
[TBL] [Abstract][Full Text] [Related]
39. Fluorescence-based viability assay for studies of reactive drug intermediates.
Leeder JS; Dosch HM; Harper PA; Lam P; Spielberg SP
Anal Biochem; 1989 Mar; 177(2):364-72. PubMed ID: 2729556
[TBL] [Abstract][Full Text] [Related]
40. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity.
Shear NH; Spielberg SP; Grant DM; Tang BK; Kalow W
Ann Intern Med; 1986 Aug; 105(2):179-84. PubMed ID: 3729200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
